Südzucker AG
Südzucker AG (SUEZY) Financial Performance & Income Statement Overview
Analyze Südzucker AG (SUEZY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Südzucker AG (SUEZY) Income Statement & Financial Overview
Explore comprehensive income reports for Südzucker AG SUEZY, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.23B | $2.37B | $2.54B | $2.55B |
| Cost of Revenue | $0.00 | $0.00 | $1.80B | $0.00 |
| Gross Profit | $2.23B | $2.37B | $744.00M | $2.55B |
| Gross Profit Ratio | $1.00 | $1.00 | $0.29 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.30B | $0.00 | $292.00M | $0.00 |
| Operating Expenses | $2.37B | $2.41B | $613.00M | $2.32B |
| Total Costs & Expenses | $2.37B | $2.41B | $2.41B | $2.40B |
| Interest Income | $0.00 | $0.00 | $6.00M | $0.00 |
| Interest Expense | $28.00M | $25.00M | $34.00M | $23.00M |
| Depreciation & Amortization | $0.00 | $85.00M | $76.00M | $75.00M |
| EBITDA | -$128.00M | -$33.00M | $213.00M | $230.00M |
| EBITDA Ratio | -$0.06 | -$0.01 | $0.08 | $0.09 |
| Operating Income | -$140.00M | -$33.00M | $131.00M | $155.00M |
| Operating Income Ratio | -$0.06 | -$0.01 | $0.05 | $0.06 |
| Other Income/Expenses (Net) | $40.00M | -$110.00M | -$28.00M | -$23.00M |
| Income Before Tax | -$100.00M | -$143.00M | $103.00M | $130.00M |
| Income Before Tax Ratio | -$0.04 | -$0.06 | $0.04 | $0.05 |
| Income Tax Expense | $19.00M | -$15.00M | $36.00M | $38.00M |
| Net Income | -$101.00M | -$119.00M | $59.00M | $83.00M |
| Net Income Ratio | -$0.05 | -$0.05 | $0.02 | $0.03 |
| EPS | -$0.53 | -$0.62 | $0.25 | $0.41 |
| Diluted EPS | -$0.53 | -$0.62 | $0.25 | $0.41 |
| Weighted Avg Shares Outstanding | $204.18M | $191.94M | $236.00M | $204.10M |
| Weighted Avg Shares Outstanding (Diluted) | $204.18M | $191.94M | $236.00M | $204.10M |
Over the past four quarters, Südzucker AG demonstrated steady revenue growth, increasing from $2.55B in Q1 2024 to $2.23B in Q4 2024. Operating income reached -$140.00M in Q4 2024, maintaining a consistent -6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$128.00M, reflecting operational efficiency. Net income rose to -$101.00M, with EPS at -$0.53. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan